R Luzzi
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
Papers in ⓘ
- Surgery 15
- Diagnosis and Treatment of Venous Diseases 7
- Lipoproteins and Cardiovascular Health 4
- Peripheral Artery Disease Management 4
-
- Medicinal Plants and Neuroprotection 6
- Co-authors
- Mark Dugall (59 shared papers)Beatrice Feragalli (37 shared papers)Umberto Cornelli (24 shared papers)Gianni Belcaro (23 shared papers)E. Ippolito (25 shared papers)M R Cesarone (28 shared papers)A Ledda (19 shared papers)Masako Hosoi (19 shared papers)
- Journals
- Blood (1 paper)Phytotherapy Research (1 paper)Planta Medica (1 paper)Phytomedicine (1 paper)Evidence-based Complementary and Alternative Medicine (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
R Luzzi
64 papers receiving 633 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 99
- Biochemistry 108
- Internal Medicine 59
- Complementary and alternative medicine 98
- Pharmacology 106
Countries citing papers authored by R Luzzi
This map shows the geographic impact of R Luzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Luzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Luzzi more than expected).
Fields of papers citing papers by R Luzzi
This network shows the impact of papers produced by R Luzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Luzzi. The network helps show where R Luzzi may publish in the future.
Co-authors
The 25 scholars most cited alongside R Luzzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. | 2011 | 77 |
| 2 | 1997 | 40 | |
| 3 | Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. | 2012 | 38 |
| 4 | 2013 | 27 | |
| 5 | 2018 | 26 | |
| 6 | Pycnogenol® improvements in asthma management. | 2011 | 26 |
| 7 | 2014 | 23 | |
| 8 | TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. | 2011 | 21 |
| 9 | Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study. | 2015 | 19 |
| 10 | Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression. | 2015 | 18 |
| 11 | 2016 | 17 | |
| 12 | Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. | 2014 | 16 |
| 13 | Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression. | 2014 | 15 |
| 14 | 2016 | 15 | |
| 15 | Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. | 2015 | 14 |
| 16 | Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. | 2011 | 14 |
| 17 | Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract. | 2016 | 13 |
| 18 | Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55. | 2014 | 13 |
| 19 | 2017 | 12 | |
| 20 | Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study. | 2015 | 12 |
About R Luzzi
R Luzzi is a scholar working on Surgery, Complementary and alternative medicine, Internal Medicine, Rheumatology and Pharmacology, having authored 66 papers that have together received 673 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (8 papers), Diagnosis and Treatment of Venous Diseases (7 papers), Medicinal Plants and Neuroprotection (6 papers), Pharmacological Effects of Medicinal Plants (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Peripheral Artery Disease Management (4 papers). The work is most often cited by research in Molecular Medicine (99 citations), Biochemistry (108 citations), Internal Medicine (59 citations), Complementary and alternative medicine (98 citations) and Pharmacology (106 citations). R Luzzi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Mark Dugall, Beatrice Feragalli, Umberto Cornelli, Gianni Belcaro, E. Ippolito, M R Cesarone, A Ledda, Masako Hosoi, Morio Hosoi and Gianni Belcaro. Their work appears in journals such as Blood, Phytotherapy Research, Planta Medica, Phytomedicine and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.